Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis
Gespeichert in:
Verfasser / Beitragende:
[J Dequeker, C Hawkey, A Kahan, K Steinbrück, C Alegre, E Baumelou, B Bégaud, H Isomäki, G Littlejohn, J Mau, S Papazoglou]
Ort, Verlag, Jahr:
1998
Enthalten in:
British journal of rheumatology, 37/9(1998-), 946-951
Format:
Artikel (online)
Online Zugang: